Michael Walega

Head, Centralized Monitoring

Michael Walega is the Head of Centralized Monitoring at BMS. In this capacity, he is responsible for providing protocol teams with actionable insights to achieve higher quality, ensure that centralized monitoring processes are aligned to relevant regulatory requirements, and championing risk-based quality management approaches to clinical trial monitoring activities. He was previously at LabCorp/Covance, where he led the team responsible for development and growth of Covance’s Risk-Based Monitoring (RBM) solutions, processes, and operational delivery. Additionally, while at Covance he also led the Late Stage Biostatistics and Programming groups, as well as the Process Excellence team. Mike is a qualified Biostatistician and a Six Sigma Master Black Belt.

Talks About
#pharmaceutical #management

Preferred Locations
#Northamerica